The Trendlines Group

15/04/2026

18/12/2025

Turning the "Ick-Factor" into the "X-Factor"....

11/12/2025

סבב הגיוס של HARP Diagnostics פתוח להשקעה

24/11/2025

Sometimes it's challenging to explain who we are and what we do at Trendlines. Here's a 3-minute video encapsulation of just that >>>
Thanks to Harel and the team at Veople

25/05/2025

היום ב-12:00: ישראל עוצרת!
היום ב־12:00 נעצור שוב – כי אין ברירה אחרת. אנחנו עוצרים כדי להשפיע על המציאות, כדי לומר לחברים בעבודה, לשכנים, ולממשלה: לא נוותר על החטופים. לא נוותר על שלטון החוק והדמוקרטיה. ולא נקבל את המלחמה כגורל.

24/12/2024

🎁 This Christmas, thousands of hashtag will receive the best gift from portfolio company Escala Medical. The team worked really hard, converting meeting rooms into packaging rooms, to get the shipment of their hashtag kits out. Mendit provides an innovative non-surgical solution to pelvic prolapse.
🎉 Happy holidays and a healthy 2025 to all those who will benefit from their groundbreaking technology.

Edit Goldberg

10/12/2024

Read our December 2024 news here: https://mailchi.mp/trendlines/trendlines-group-trendletter-december24?e=ee40359ea6

12/05/2024

Portfolio company Vessi Medical closed a $16.5 Million Series A Round for its innovative treatment. Investors in the round included a global strategic investor, ALIVE Israel HealthTech Fund and Agriline. Well done to Eyal Kochavן and the team!
Read the full details here:

https://www.trendlines.com/news/vessi-medical-closes-16-5-million-series-a-round-for-innovative-cryotherapy-bladder-cancer-treatment/

07/02/2024

Wishing all our partners, colleagues and friends who celebrate, a Happy New Year of the Dragon. May it be a year filled with prosperity, joy and good fortune!

19/12/2023

"Just days after October 7, the Israeli Ministry of Agriculture warned that 70 percent of Israel’s tomato crops – inside some 4,000 acres of greenhouses in the south – could go unharvested.

And while many Israelis have answered the call to help bring in the harvest, there are simply not enough hands to gather all the crops.

But Metomotion says its Greenhouse Robotic Worker (GRoW) device can do the job, using artificial intelligence and 3D imaging to autonomously identify and pick just the ripe tomatoes."

Stepping up to the challenge, both the tech of Metomotion in addressing the shortage of workers (a worldwide problem, not unique to Israel), coupled with the amazing resilience of the agriculturalists in Israel's south, who despite all odds and personall tragedies, are rebuilding stronger and better than ever before.

Thank you to NoCamels - Israeli Innovation News for bringing their stories to light.

Nitza Kardish Barak Singer Israel Innovation Authority GrowingIL | Agtech Community

MetoMotion's Greenhouse Robotic Worker (GRoW) uses AI and 3D imaging to autonomously identify and pick ripe tomatoes.

11/09/2023

clearance! Well done to portfolio company Limaca Medical for the achievement of this amazing milestone. Congrats to the team and partners in the effort!

Limaca Medical announced today that its Precision GI™ Endoscopic Ultrasound (EUS) Biopsy Device received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”). This follows Limaca’s receipt of FDA Breakthrough Device Designation for its Precision GI™.

22/08/2023

NextInsight covered our H1 2023 earnings call last week with this write-up.
*Laser-focused on achieving exits of mature portfolio companies*

Trendlines had said it would, starting in 2023, suspend investments in new start-ups.

This may sound like a minor fine-tuning of capital and management resources -- but Chairman Steve Rhodes' elaboration this week on a H1 2023 earnings call provides a deeper insight:
"I don't think you can imagine how much time and effort and capital are required to start new companies. It's not a minor issue. We were reviewing more than 600 opportunities a year. Narrowing that down -- it's a long complicated process and then bringing those companies into the shop where we provided significant capital and significant management timing and resources. Today, all of the capital, all of that management time has been freed up to focus on our existing portfolio companies and focus on getting to exits."

Read the full article here:

a hub for serious investors